Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus
By Patrick Wingrove (Reuters) - Novo Holdings, the controlling shareholder of Novo Nordisk (NYSE:NVO), hopes to double the size of its recently acquired contract drugmaker...